(0.15%) 5 468.57 points
(0.02%) 39 128 points
(0.65%) 17 849 points
(2.31%) $83.42
(-4.54%) $2.48
(0.03%) $2 340.30
(0.39%) $29.68
(-2.33%) $990.50
(-0.18%) $0.931
(-0.10%) $10.66
(0.03%) $0.791
(1.05%) $86.62
Live Chart Being Loaded With Signals
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 132 153 |
平均出来高 | 254 677 |
時価総額 | 3.40B |
EPS | $0.990 ( Q4 | 2024-05-15 ) |
次の収益日 | ( $0.870 ) 2024-08-01 |
Last Dividend | $0.475 ( 2018-09-27 ) |
Next Dividend | $0 ( N/A ) |
P/E |
16.42 (Sector) 49.64 (Industry) 27.21 |
ATR14 | $0.0420 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-07 | Lombardi Ronald M. | Buy | 14 298 | Common Stock, par value $0.01 per share |
2024-05-07 | Mekhail Adel | Buy | 3 020 | Common Stock, par value $0.01 per share |
2024-05-07 | Zerillo Jeffrey | Buy | 2 116 | Common Stock, par value $0.01 per share |
2024-05-07 | Sacco Christine | Buy | 6 062 | Common Stock, par value $0.01 per share |
2024-05-07 | P'pool William | Buy | 3 123 | Common Stock, par value $0.01 per share |
INSIDER POWER |
---|
-2.39 |
Last 99 transactions |
Buy: 314 062 | Sell: 339 954 |
ボリューム 相関
Prestige Consumer 相関
10 最も正の相関 | |
---|---|
BWLP | 0.968 |
PACS | 0.945 |
OBDC | 0.941 |
CNDA-UN | 0.938 |
VLTO | 0.92 |
ELME | 0.918 |
NEE-PR | 0.913 |
HAFN | 0.912 |
AMBP | 0.907 |
TFPM | 0.899 |
10 最も負の相関 | |
---|---|
QBTS | -0.938 |
BYON | -0.929 |
MPU | -0.929 |
AMBI | -0.926 |
CIO | -0.914 |
CCG | -0.913 |
HR | -0.908 |
FLNG | -0.908 |
KW | -0.903 |
MKFG-WT | -0.902 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Prestige Consumer 相関 - 通貨/商品
Prestige Consumer 財務諸表
Annual | 2024 |
収益: | $1.13B |
総利益: | $601.90M (53.48 %) |
EPS: | $4.21 |
FY | 2024 |
収益: | $1.13B |
総利益: | $601.90M (53.48 %) |
EPS: | $4.21 |
FY | 2023 |
収益: | $1.13B |
総利益: | $625.29M (55.45 %) |
EPS: | $-1.650 |
FY | 2022 |
収益: | $1.09B |
総利益: | $620.65M (57.11 %) |
EPS: | $4.09 |
Financial Reports:
Symbol | Period | Year | Title |
---|---|---|---|
PBH | FY | 2024 | Prestige Consumer Healthcare Inc Q4 2024 Financial Results |
Prestige Consumer Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.475 | 2018-09-27 |
Last Dividend | $0.475 | 2018-09-27 |
Next Dividend | $0 | N/A |
Payout Date | 2018-10-15 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.475 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.51 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.54 | |
Div. Directional Score | 8.35 | -- |
Year | Amount | Yield |
---|---|---|
2018 | $0.475 | 1.08% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
27 Sep 2018 | $0.475 | 30 Nov -0001 | 30 Nov -0001 | 15 Oct 2018 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ECC | Dividend Diamond | 2024-07-11 | Monthly | 11 | 14.91% | 9.72 |
BRW | Dividend Diamond | 2024-06-11 | Monthly | 33 | 9.41% | 9.26 |
VVR | Dividend Diamond | 2024-06-18 | Monthly | 27 | 8.85% | 9.19 |
FCT | Dividend Diamond | 2024-06-03 | Monthly | 21 | 8.33% | 9.14 |
PHK | Dividend Diamond | 2024-06-13 | Monthly | 22 | 9.07% | 9.13 |
SBR | Dividend Diamond | 2024-06-17 | Monthly | 38 | 9.57% | 9.10 |
XFLT | Dividend Diamond | 2024-06-17 | Monthly | 8 | 10.49% | 9.09 |
SRV | Dividend Royal | 2024-07-16 | Monthly | 18 | 10.61% | 9.04 |
FAM | Dividend Royal | 2024-06-03 | Monthly | 20 | 8.07% | 8.98 |
RA | Dividend Diamond | 2024-06-11 | Monthly | 9 | 10.10% | 8.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.186 | 1.500 | 6.28 | 9.42 | [0 - 0.5] |
returnOnAssetsTTM | 0.0624 | 1.200 | 7.92 | 9.51 | [0 - 0.3] |
returnOnEquityTTM | 0.134 | 1.500 | 9.63 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.20 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.907 | 0.800 | 3.49 | 2.79 | [0.8 - 2.5] |
cashRatioTTM | 0.397 | 1.500 | 8.91 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.337 | -1.500 | 4.38 | -6.57 | [0 - 0.6] |
interestCoverageTTM | 5.10 | 1.000 | 9.22 | 9.22 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.00 | 2.00 | 8.33 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.80 | 2.00 | 7.60 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.684 | -1.500 | 7.26 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.550 | 1.000 | 4.17 | 4.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.304 | 1.000 | 5.91 | 5.91 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.220 | 1.000 | 9.89 | 9.89 | [0.2 - 2] |
assetTurnoverTTM | 0.335 | 0.800 | -1.098 | -0.879 | [0.5 - 2] |
Total Score | 11.15 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 16.39 | 1.000 | 8.45 | 0 | [1 - 100] |
returnOnEquityTTM | 0.134 | 2.50 | 9.76 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.80 | 2.00 | 8.40 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.00 | 2.00 | 8.33 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 3.92 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.221 | 1.000 | 6.97 | 0 | [0.1 - 0.5] |
Total Score | 5.54 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Prestige Consumer
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。